Nimbus Therapeutics Appoints Mark Iwicki And George Vlasuk To Its Board Of Directors
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nimbus Therapeutics, a biotechnology company focused on harnessing the power of computational chemistry to design breakthroughs for serious, underserved diseases, today announced the appointment of industry leaders Mark Iwicki and George P. Vlasuk, Ph.D., as independent members of its Board of Directors.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.